DK42099A - Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman - Google Patents

Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Info

Publication number
DK42099A
DK42099A DK199800420A DK42098A DK42099A DK 42099 A DK42099 A DK 42099A DK 199800420 A DK199800420 A DK 199800420A DK 42098 A DK42098 A DK 42098A DK 42099 A DK42099 A DK 42099A
Authority
DK
Denmark
Prior art keywords
iron
prevention
treatment
component
therapeutic agent
Prior art date
Application number
DK199800420A
Other languages
English (en)
Other versions
DK172860B1 (da
Inventor
Andreasen Hans Berg
Christensen Lars
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8093321&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK42099(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Priority to DK199800420A priority Critical patent/DK172860B1/da
Priority to CNB998042498A priority patent/CN1147322C/zh
Priority to UA2000095459A priority patent/UA70939C2/uk
Priority to EP99908785A priority patent/EP1066056B2/en
Priority to HU0101189A priority patent/HU228483B1/hu
Priority to TR2000/02733T priority patent/TR200002733T2/xx
Priority to ES99908785T priority patent/ES2180279T5/es
Priority to CA002322633A priority patent/CA2322633C/en
Priority to JP2000537579A priority patent/JP4558198B2/ja
Priority to PCT/DK1999/000160 priority patent/WO1999048533A1/en
Priority to DE69902154T priority patent/DE69902154T3/de
Priority to AT99908785T priority patent/ATE220560T1/de
Priority to AU28273/99A priority patent/AU740432B2/en
Priority to SI9930103T priority patent/SI1066056T2/sl
Priority to IDW20001881A priority patent/ID26778A/id
Priority to HK01104034.9A priority patent/HK1033426B/en
Priority to PT99908785T priority patent/PT1066056E/pt
Priority to CZ20003535A priority patent/CZ300823B6/cs
Priority to ARP990101309A priority patent/AR015738A1/es
Priority to DK99908785T priority patent/DK1066056T4/da
Priority to PL99343164A priority patent/PL195582B1/pl
Priority to US09/509,454 priority patent/US6291440B1/en
Priority to KR1020007010563A priority patent/KR100612071B1/ko
Priority to BRPI9908914-9 priority patent/BRPI9908914B8/pt
Priority to SK1409-2000A priority patent/SK284499B6/sk
Priority to EA200000981A priority patent/EA003427B1/ru
Priority to NZ505983A priority patent/NZ505983A/xx
Publication of DK42099A publication Critical patent/DK42099A/da
Publication of DK172860B1 publication Critical patent/DK172860B1/da
Application granted granted Critical
Priority to ZA200004016A priority patent/ZA200004016B/xx
Priority to NO20004151A priority patent/NO329591B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK199800420A 1998-03-25 1998-03-25 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman DK172860B1 (da)

Priority Applications (29)

Application Number Priority Date Filing Date Title
DK199800420A DK172860B1 (da) 1998-03-25 1998-03-25 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
IDW20001881A ID26778A (id) 1998-03-25 1999-03-24 SENYAWA ZAT BESI-DEKSTRAN UNTUK DIGUNAKAN SEBAGAI KOMPONEN PADA KOMPOSISI TERAPEUTIK UNTUK PENCEGAHAN ATAU PENGOBATAN KEKURANGAN ZAT BESI, ......... SECARA PARENTERAL (judul disingkat untuk bisa di update
HK01104034.9A HK1033426B (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
EP99908785A EP1066056B2 (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
HU0101189A HU228483B1 (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
TR2000/02733T TR200002733T2 (tr) 1998-03-25 1999-03-24 Demir-eksikliğinin önlenmesi veya tedavisi için bir tedavi edici bileşimde bir bileşen olarak kullanım için bir demir-dekstran bileşiği ve üretilmesi için bir işlem
ES99908785T ES2180279T5 (es) 1998-03-25 1999-03-24 Compuesto hierro-dextrano para utilizacion como componente en composicion terapeutica para profilaxis o tratamiento de deficiencia de hierro, procedimiento para su produccion y su utilizacion para prepararacion composicion terapeutica que se puede administrar por via parenteral.
CA002322633A CA2322633C (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
JP2000537579A JP4558198B2 (ja) 1998-03-25 1999-03-24 鉄欠乏症の予防または治療のための治療組成物の成分として用いる鉄−デキストラン化合物、および前記鉄−デキストラン化合物の製造法
PCT/DK1999/000160 WO1999048533A1 (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
DE69902154T DE69902154T3 (de) 1998-03-25 1999-03-24 Eisen-dextran verbindung zur verwendung als komponente in einer therapeutischen zusammensetzung zur behandlung oder prophylaxe von eisenmangel, sowie verfahren zur herstellung der eisen-dextran verbindung und ihre anwendung zur herstellung einer parenteral anwendbaren therapeutischen zubereitung.
AT99908785T ATE220560T1 (de) 1998-03-25 1999-03-24 Eisen-dextran verbindung zur verwendung als komponente in einer therapeutischen zusammensetzung zur behandlung oder prophylaxe von eisenmangel, sowie verfahren zur herstellung der eisen-dextran verbindung und ihre anwendung zur herstellung einer parenteral anwendbaren therapeutischen zubereitung.
AU28273/99A AU740432B2 (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutic composition
SI9930103T SI1066056T2 (sl) 1998-03-25 1999-03-24 Spojina železo-dekstran za uporabo kot komponenta v terapevtskem sestavku za profilakso ali zdravljenje pomanjkanja železa, postopek za pripravo te železo-dekstran spojine in uporaba te spojine za pripravo terapevtskega sestavka, ki ga je mogoče
CNB998042498A CN1147322C (zh) 1998-03-25 1999-03-24 铁-葡聚糖化合物及其制备方法和用途
PT99908785T PT1066056E (pt) 1998-03-25 1999-03-24 Composto de ferro-dextrano para utilizacao como componente de uma composicao terapeutica para a profilaxia ou tratamento da carencia de ferro processo de producao do referido composto de ferro-dextrano e utilizacao desse mesmo composto na preparacao de uma composicao terapeutica de administracao parenterica
DK99908785T DK1066056T4 (da) 1998-03-25 1999-03-24 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
UA2000095459A UA70939C2 (uk) 1998-03-25 1999-03-24 Залізо-декстранова сполука для профілактики або лікування дефіциту заліза, спосіб її приготування (варіанти)
ARP990101309A AR015738A1 (es) 1998-03-25 1999-03-24 "un compuesto de hierro-dextrano, una composicion, un proceso para producir dicho compuesto de hierro-dextrano, uso de dicho compuesto para la preparacion de una composicion terapeutica administrable parenteralmente para utilizar como un componente en una composicion terapeutica para la profilaxis o
CZ20003535A CZ300823B6 (cs) 1998-03-25 1999-03-24 Sloucenina železa a dextranu
PL99343164A PL195582B1 (pl) 1998-03-25 1999-03-24 Kompleks asocjacyjny oksywodorotlenku żelaza(III)i uwodornionego dekstranu, sposób wytwarzania tego kompleksu, zastosowanie tego kompleksu i sposób wytwarzania płynu do iniekcji zawierającego ten kompleks
US09/509,454 US6291440B1 (en) 1998-03-25 1999-03-24 Iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency
KR1020007010563A KR100612071B1 (ko) 1998-03-25 1999-03-24 철분-결핍증의 예방 또는 치료를 위한 치료 조성물의 성분으로 사용하는 철-덱스트란 화합물, 상기 철-덱스트란 화합물을 제조하는 방법 및 상기 화합물을 비경구적으로 투여 가능한 치료 조성물의 제조에 사용하는 방법
BRPI9908914-9 BRPI9908914B8 (pt) 1998-03-25 1999-03-24 composto de ferro-dextrana para uso como um componente em uma composiÇço terapÊutica, para profilaxia ou tratamento de deficiÊncia de ferro; processo para a produÇço do referido composto de ferro-dextrana e uso do referido composto para preparaÇço de uma composiÇço terapÊutica parenteralmente administrÁvel.
SK1409-2000A SK284499B6 (sk) 1998-03-25 1999-03-24 Železito-dextránová zlúčenina, spôsob jej výroby a jej použitie
EA200000981A EA003427B1 (ru) 1998-03-25 1999-03-24 Железо-декстрановое соединение для применения в качестве компонента терапевтической композиции для профилактики или лечения дефицита железа, способ получения указанного железо-декстранового соединения и применение указанного соединения для изготовления терапевтической композиции для парентерального введения
NZ505983A NZ505983A (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
ZA200004016A ZA200004016B (en) 1998-03-25 2000-08-07 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition.
NO20004151A NO329591B1 (no) 1998-03-25 2000-08-18 Jerndekstranforbindelse for bruk som en komponent i en terapeutisk blanding for profylaske eller behandling av jernmangel, en fremgangsmate for fremstilling av jerndekstranforbindelsen og anvendelse av forbindelsen for fremstilling av en parental administrerbar terapeutisk blanding.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK42098 1998-03-25
DK199800420A DK172860B1 (da) 1998-03-25 1998-03-25 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Publications (2)

Publication Number Publication Date
DK42099A true DK42099A (da) 1999-08-16
DK172860B1 DK172860B1 (da) 1999-08-16

Family

ID=8093321

Family Applications (2)

Application Number Title Priority Date Filing Date
DK199800420A DK172860B1 (da) 1998-03-25 1998-03-25 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK99908785T DK1066056T4 (da) 1998-03-25 1999-03-24 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK99908785T DK1066056T4 (da) 1998-03-25 1999-03-24 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...

Country Status (27)

Country Link
US (1) US6291440B1 (da)
EP (1) EP1066056B2 (da)
JP (1) JP4558198B2 (da)
KR (1) KR100612071B1 (da)
CN (1) CN1147322C (da)
AR (1) AR015738A1 (da)
AT (1) ATE220560T1 (da)
AU (1) AU740432B2 (da)
BR (1) BRPI9908914B8 (da)
CA (1) CA2322633C (da)
CZ (1) CZ300823B6 (da)
DE (1) DE69902154T3 (da)
DK (2) DK172860B1 (da)
EA (1) EA003427B1 (da)
ES (1) ES2180279T5 (da)
HU (1) HU228483B1 (da)
ID (1) ID26778A (da)
NO (1) NO329591B1 (da)
NZ (1) NZ505983A (da)
PL (1) PL195582B1 (da)
PT (1) PT1066056E (da)
SI (1) SI1066056T2 (da)
SK (1) SK284499B6 (da)
TR (1) TR200002733T2 (da)
UA (1) UA70939C2 (da)
WO (1) WO1999048533A1 (da)
ZA (1) ZA200004016B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
JP5064612B2 (ja) * 1999-04-09 2012-10-31 エーエムエージー ファーマシューティカルズ，インコーポレイテッド 還元された炭水化物類及び炭水化物誘導体で被覆された熱的に安定なコロイド状酸化鉄
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
KR20020003344A (ko) * 2001-12-17 2002-01-12 유형선 철분 보급제 경구 투여 제제 조성물
ATE335008T1 (de) * 2002-04-09 2006-08-15 Pharmacosmos Holding As Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (de) 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
EP1947120A1 (de) * 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
EP1997833A1 (de) * 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
CN101585887B (zh) * 2008-05-22 2011-12-14 中国科学院过程工程研究所 应用纳滤技术对右旋糖酐铁络合物水溶液进行脱盐和浓缩的方法
BRPI0924653B8 (pt) 2009-03-25 2021-05-25 Pharmacosmos Holding As composto de ferro-oligossacarídeo, composição e uso de deste composto
CN101967205B (zh) * 2010-10-12 2013-04-17 滨州学院 一种β-葡聚糖铁复合物及其制备方法
EP2537866A1 (en) 2011-06-21 2012-12-26 Serumwerk Bernburg AG Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
PL398814A1 (pl) 2012-04-16 2013-10-28 Uniwersytet Jagiellonski Zastosowanie pochodnych dekstranu do przeciwdzialania lub leczenia niedokrwistosci
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US11040059B2 (en) * 2014-10-27 2021-06-22 Pharmacosmos Holding A/S Treatment or prevention of anaemia in pregnant non-human mammals
SG11202001594TA (en) * 2017-09-11 2020-03-30 Pharmacosmos Holding As Iron complex compounds for therapeutic use
KR102920596B1 (ko) * 2018-05-16 2026-01-30 세바 상뜨 아니말르 수의학적 조성물 및 이의 비-인간 포유동물에서 철 결핍을 조절하기 위한 용도
CN109646454A (zh) * 2018-12-29 2019-04-19 博瑞生物医药（苏州）股份有限公司 异麦芽糖酐铁1000的制备方法
CN110183548B (zh) * 2019-06-28 2021-05-18 瑞普（天津）生物药业有限公司 一种低分子葡聚糖铁的制备方法及其应用
AU2022323733A1 (en) 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE24642E (en) 1959-04-28 Therapeutic preparations of iron
DK117730A (da)
US2885393A (en) 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3093545A (en) 1960-08-29 1963-06-11 Armour Pharma Therapeutic iron-dextran preparations
US3234209A (en) * 1963-09-13 1966-02-08 Chemicals Inc Process for making iron hydrogenated dextran
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
GB1200902A (en) 1967-05-13 1970-08-05 Fisons Pharmaceuticals Ltd Iron-dextran complexes
CH507993A (de) 1967-07-13 1971-05-31 Kutnowskie Zakl Farma Verfahren zur Herstellung von Eisen(III)-komplexverbindungen mit hydriertem Dextran
DK129353B (da) 1968-04-29 1974-09-30 Fisons Pharmaceuticals Ltd Analogifremgangsmåde til fremstilling af et ferrihydroxid-dextranderivatkompleks eller en opløsning deraf.
US3697502A (en) 1969-11-03 1972-10-10 Christensen Henry M Method of making iron dextran-preparations
GB1562913A (en) * 1976-06-16 1980-03-19 Fisons Ltd Fractionating fluid mixtures of dextrans
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
RU2093577C1 (ru) * 1993-11-04 1997-10-20 Государственный институт кровезаменителей и медицинских препаратов Способ получения декстрана
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
US5624668A (en) * 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations

Also Published As

Publication number Publication date
JP2002507582A (ja) 2002-03-12
AR015738A1 (es) 2001-05-16
CA2322633C (en) 2009-01-27
ES2180279T5 (es) 2009-05-05
SI1066056T2 (sl) 2009-04-30
TR200002733T2 (tr) 2000-12-21
EA200000981A1 (ru) 2001-02-26
PL343164A1 (en) 2001-07-30
ID26778A (id) 2001-02-08
ZA200004016B (en) 2001-07-25
HK1033426A1 (en) 2001-08-31
CN1147322C (zh) 2004-04-28
PL195582B1 (pl) 2007-10-31
DE69902154T3 (de) 2009-07-09
WO1999048533A1 (en) 1999-09-30
BRPI9908914A (pt) 2000-11-21
BRPI9908914B1 (pt) 2012-06-12
UA70939C2 (uk) 2004-11-15
HUP0101189A2 (hu) 2001-08-28
NO20004151L (no) 2000-08-18
NZ505983A (en) 2002-11-26
AU2827399A (en) 1999-10-18
CN1293577A (zh) 2001-05-02
NO329591B1 (no) 2010-11-15
SI1066056T1 (en) 2002-12-31
EP1066056B1 (en) 2002-07-17
NO20004151D0 (no) 2000-08-18
DE69902154T2 (de) 2003-03-06
DK172860B1 (da) 1999-08-16
SK284499B6 (sk) 2005-05-05
ES2180279T3 (es) 2003-02-01
SK14092000A3 (sk) 2001-04-09
US6291440B1 (en) 2001-09-18
EP1066056B2 (en) 2008-12-10
DK1066056T4 (da) 2009-04-14
DK1066056T3 (da) 2002-10-14
ATE220560T1 (de) 2002-08-15
AU740432B2 (en) 2001-11-01
EP1066056A1 (en) 2001-01-10
CA2322633A1 (en) 1999-09-30
BRPI9908914B8 (pt) 2021-07-06
CZ20003535A3 (cs) 2001-04-11
HUP0101189A3 (en) 2003-12-29
EA003427B1 (ru) 2003-04-24
HU228483B1 (en) 2013-03-28
CZ300823B6 (cs) 2009-08-19
JP4558198B2 (ja) 2010-10-06
DE69902154D1 (de) 2002-08-22
KR100612071B1 (ko) 2006-08-11
KR20010034641A (ko) 2001-04-25
PT1066056E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
DK1066056T3 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, ...
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
DK2412368T3 (da) Sammensætning til behandling af ar
NO20021474D0 (no) Forbindelser for behandling av ischemi
IS8586A (is) Oxabispidínefnasambönd sem eru gagnleg til að meðhöndla hjartsláttartruflanir
NO952749D0 (no) Middel for vannbehandling
EE200000741A (et) Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks
NO995500L (no) Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
ZA991578B (en) Compounds for the treatment of ischemia.
NO20052626D0 (no) Middel for forhindring eller behandling av neuropati
DK1250152T3 (da) Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
PT1300084E (pt) Composicaio para o tratamento de insuficiencias venosas cronicas melha.
DK1206436T3 (da) Retinoider til behandling af emfysem
BR9706908A (pt) Composiçães para o tratamento de insuficiéncia renal compreendendo l-carnosina
PT853959E (pt) Composicao para o tratamento do amianto
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
NO20022253L (no) Middel til behandling av hepatitt C
AU2003263978A8 (en) 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
DK0631733T3 (da) Enzymatisk middel til forbedring af mørningen af kød
NO20012616D0 (no) Middel til behandling av erektil malfunksjon

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK